TherapeuticsMD, Inc. (TXMD): Price and Financial Metrics

TXMD POWR Grades

• Value is the dimension where TXMD ranks best; there it ranks ahead of 62.36% of US stocks.
• TXMD's strongest trending metric is Momentum; it's been moving down over the last 62 days.
• TXMD's current lowest rank is in the Momentum metric (where it is better than 20.86% of US stocks).

TXMD Stock Summary

• With a price/earnings ratio of 0.42, THERAPEUTICSMD INC P/E ratio is greater than that of about only 0.13% of stocks in our set with positive earnings.
• Of note is the ratio of THERAPEUTICSMD INC's sales and general administrative expense to its total operating expenses; 99.19% of US stocks have a lower such ratio.
• The ratio of debt to operating expenses for THERAPEUTICSMD INC is higher than it is for about only 0.2% of US stocks.
• Stocks that are quantitatively similar to TXMD, based on their financial statements, market capitalization, and price volatility, are AGE, GGB, FTFT, AMCR, and CPHI.
• Visit TXMD's SEC page to see the company's official filings. To visit the company's web site, go to www.therapeuticsmd.com.

TXMD Valuation Summary

• In comparison to the median Healthcare stock, TXMD's price/sales ratio is 754.05% higher, now standing at 15.8.
• TXMD's price/sales ratio has moved down 85.1 over the prior 142 months.

Below are key valuation metrics over time for TXMD.

TXMD Growth Metrics

The 4 year net cashflow from operations growth rate now stands at -137.17%.
• Its 2 year price growth rate is now at -95.09%.
• Its 3 year price growth rate is now at -98.3%.

Over the past 15 months, TXMD's revenue has gone up $2,701,410.

The table below shows TXMD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	87.489	-103.408	-8.665
2022-06-30	91.978	-122.711	-27.12
2022-03-31	86.418	-133.839	-182.053
2021-12-31	86.951	-142.693	-172.415
2021-09-30	90.85079	-133.4563	-171.5426
2021-06-30	84.78759	-129.282	-156.7337

TXMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• TXMD has a Quality Grade of D, ranking ahead of 19.35% of graded US stocks.
• TXMD's asset turnover comes in at 0.419 -- ranking 109th of 682 Pharmaceutical Products stocks.
• ALNY, QGEN, and CASI are the stocks whose asset turnover ratios are most correlated with TXMD.

The table below shows TXMD's key quality metrics over time.